Intermittent Hypoxia-hyperoxia Conditioning as a New Therapeutic Intervention to Reduce Hypertension
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 72
- 试验地点
- 2
- 主要终点
- 24 hours Blood pressure change form pre to post intervention
研究概览
简要总结
The primary objective of this project is to examine the efficiency of intermittent hypoxia-hyperoxia conditioning (IHHC) protocol to improve vascular health and reduce blood pressure in hypertensive patients (stage 1). The result of the present study will investigate if IHHC could be a therapeutic treatment for hypertensive individuals. The investigation is designed with a placebo intervention (air ambient) and a control group (age-matched healthy participants). The interest of short cycles of intermittent hypoxia-hyperoxia is due to the triggering of the vasodilatory response in a greater extent compared to the pressor mechanisms since the exposure duration remains short. Therefore, it can be hypothesized that control and hypertensive groups achieving IHHC may exhibit a decreased blood pressure compared to the control and hypertensive groups achieving placebo intervention. The control group may show greater change than hypertensive due to higher vascular reserve.
The secondary objective of the study is to understand the underlying mechanism of the beneficial effects of IHHC, especially the role of blood hemorheological changes. Based on available literature, it is know that hypoxia induce an increase in blood viscosity. One may hypothesize that with such a short hypoxic dose used during IHHC, only minor change in blood viscosity may occur. However, a slight rise in blood viscosity is known to stimulate NO synthase and then to produce more NO. Hence it could be one of the mechanisms involved in the early vasodilatory response to hypoxia. These findings are in line with the reported higher NO end-product metabolites during exercise in normoxia and hypoxia in subjects who showed a rise in blood viscosity after exercise. The hypothesis is that the magnitude of IHHC beneficial effects is related to change in blood viscosity and its determinants.
详细描述
The prevalence and absolute burden of hypertension is rising worldwide and represents one of the leading modifiable risk factors for cardiovascular diseases being indirectly involved in the development of, for instance, stroke, kidney diseases, and dementia.
There is rather solid evidence supporting the assumption that intermittent and continuous hypoxia at rest or in combination with exercise is generally effective to reduce blood pressure and positively influence vascular health.
A well-designed and controlled hypoxic stimulus may induce benefits for health and is known as hypoxia conditioning (HC). Indeed, brief and repeated exposures to hypoxia trigger cellular and systemic physiological adaptations that make the organism more resilient to subsequent severe hypoxic stress, and possibly also to other stressors.
The mechanisms associated with an antihypertensive effect of moderate hypoxia may include vascular adaptions (e.g. increased vascularisation and endothelium-dependent vasodilatation) as well as adaptations in the autonomic nervous system (e.g. reduced sympathetic activity).
Hypoxia exposure leads to a multiphasic blood flow and pressure response over time. The first and immediate phase following hypoxic stimulus is characterized by a systemic vasodilation that aims to counteract the decrease in arterial oxygen (O2) content and subsequent peripheral O2 delivery. If hypoxia exposure lasts for more than few minutes, pressor mechanisms, such as sympathetic activation, a rise in arterial stiffness, an increase in endothelin-1 levels, a baroreflex dysfunction and an elevation in blood viscosity, exceed vasodilatory responses resulting in a rise of blood pressure. However, the mechanisms at the onset of the early blood pressure response are beneficial for vascular health and an improvement in vascular function following intermittent hypoxia exposure has been reported during both intermittent resting exposure (FiO2: 10-14%, 3-5 minutes of normobaric hypoxia per cycle, 3-25 cycles/day during 10 to 30 days [7]) or intermittent exposure combined with exercise (2 hrs of hypobaric hypoxic exposure (FiO2: 16.5%) with 30 minutes of moderate intensity exercise, 4 days/week during 8 weeks).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Single (Participant)
盲法说明
Single-blinded means that participants will not be inform than a half will follow a placebo intervention.
入排标准
- 年龄范围
- 44 Years 至 64 Years(Adult)
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •to be aged between 44 and 65 years old.
- •for women, post-menopausal will be considered.
- •for hypertensive group, stage 1 hypertension: systolic blood pressure (140-159 mmHg) and/or diastolic blood pressure (90-99 mmHg).
- •free of other disease than hypertension and free of anti-hypertensive treatment medication.
- •Hypertensive participants with 14 days of hypertensive drugs wash-out.
- •able to complete all sessions.
- •able to give consent.
排除标准
- •Peripheral arterial disease
- •Atrial fibrillation
- •Hypoxic congenital heart diseases
- •Pulmonary Hypertension
- •using dietary supplements or drugs which interfere with the measurements (nitrate supplementation)
结局指标
主要结局
24 hours Blood pressure change form pre to post intervention
时间窗: One week before the intervention and one week after the intervention
a major risk factor, when too high, for cardiovascular diseases will be continously measured for 24 hours.
次要结局
- Baroreflex sensitivity(One week before the intervention and one week after the intervention)
- Reactive hyperemia index(One week before the intervention and one week after the intervention)
- Vascular occlusion test (VOT)(One week before the intervention and one week after the intervention)
- Pulse wave velocity(One week before the intervention and one week after the intervention)
- Cerebrovascular reactivity to carbon dioxide (CO2)(One week before the intervention and one week after the intervention)
- Advanced oxidation protein products(One week before the intervention and one week after the intervention)
- Malondialdehyde(One week before the intervention and one week after the intervention)
- Superoxide dismutase(One week before the intervention and one week after the intervention)
- Glutathion peroxydase(One week before the intervention and one week after the intervention)
- Catalase(One week before the intervention and one week after the intervention)
- Nitric oxide end products(One week before the intervention and one week after the intervention)
- Blood viscosity (cp)(One week before the intervention and one week after the intervention)
- Blood volume(One week before the intervention and one week after the intervention)
- Plasma viscosity (cp)(One week before the intervention and one week after the intervention)
- Hematocrit(One week before the intervention and one week after the intervention)
研究者
Gregoire Millet
Associate professor
University of Lausanne
